Results 121 to 130 of about 9,063 (160)
Detection of non-travel-associated, ceftriaxone non-susceptible <i>Neisseria gonorrhoeae</i> FC428-like harbouring the mosaic <i>penA60</i> allele in Ontario, Canada. [PDF]
Komorowski AS +10 more
europepmc +1 more source
The Path of Estimated Resistance: Updates of the Estimated Number and Cost of Antimicrobial-Resistant Gonococcal Infections in Men and Women Aged 15 to 39 Years in the United States: 2018-2023. [PDF]
Kreisel KM +3 more
europepmc +1 more source
Whole genome sequencing of Neisseria gonorrhoeae among key populations in two cities of Bangladesh reveals genomic diversity and stable antimicrobial resistance. [PDF]
Alam M +7 more
europepmc +1 more source
Effect of preoperative antibiotic use on the implant success rate: a retrospective cohort study of cefixime and ornidazole in China. [PDF]
Lou A, Zhu X, Pei H, Zhou J, Li M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
DICP, 1990
Cefixime is a new orally active third-generation cephalosporin with a broad spectrum of activity against a variety of both gram-positive and -negative bacteria including many beta-lactamase-producing strains of streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, and the majority of the Enterobacteriaceae.
N J, Leggett, C, Caravaggio, M J, Rybak
openaire +2 more sources
Cefixime is a new orally active third-generation cephalosporin with a broad spectrum of activity against a variety of both gram-positive and -negative bacteria including many beta-lactamase-producing strains of streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, and the majority of the Enterobacteriaceae.
N J, Leggett, C, Caravaggio, M J, Rybak
openaire +2 more sources

